ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/26/2026
Back to search
Official data from USPTO
ENDO INJECTABLE SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ENDO INJECTABLE SOLUTIONS
ST13
US500000097219406Class
5, 10, 40, 41, 42, 44
Filing
97219406
Registration
6852494
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
03/06/2026
Trademark type
Word
Nice classes
5, 10, 40, 41, 42, 44
Filing date
01/14/2022
Registration date
09/20/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/20/2022
Last transaction
03/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
BALLSBRIDGE, DUBLIN 4, IE
Examiner
BAGLINI, KAREN
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PH HEALTH LIMITED
ENDO OPERATIONS LIMITED
Endo Pharmaceuticals Inc.
Representatives
Camille M. Miller COZEN O'CONNOR
Technical classification
Nice Classes
Class 5Class 10Class 40Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Ready-to-administer injectable pharmaceutical and medical preparations in connection with critical carecritical testingmaternal healthanesthesiafor the treatment of painallergic reactionshypotensionshockmalignant diseaseskidney disorderscelluliteskin caredermatological usefoldsscarsbody contouring and for rejuvenating the skinto provide and reverse muscle relaxation; all to be used in patient care facilitieshospitalsacute care facilitieslong term care facilities and in doctor's offices
Class 10
Injection syringes; Injection device for pharmaceuticals and medicine
Class 40
Manufacture of pharmaceutical products to order and specification of others; Providing technical information in the field of pharmaceutical manufacturing
Class 41
Educational servicesconducting classesseminarsworkshops in the field of pharmaceutical preparations and medicinesmedical devices and techniques; Educational servicesconducting classesseminarsworkshops and training for doctorsnurses and others in the fields of critical carecritical testingmaternal healthrare diseases and conditionsanesthesiaaesthetic solutions to help patients feel better about their bodies
Class 42
Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Medical research in the fields of chemicals and pharmaceuticals; Scientific research and testing services in the fields of chemicals and pharmaceuticals; Research and development of new products for others in the fields of chemicals and pharmaceuticals; Development of pharmaceutical products to specifications of others
Class 44
Providing medical information and online medical information on the subjects of pharmaceutical preparations and medicinesmedical devices and techniques; providing medical information and online medical and healthcare information to healthcare professionals and patients; Providing a website featuring medical information; Providing medication counseling informationadvice and data on the subjects of pharmaceutical preparations and medicines
Publications
History of USPTO decisions and trademark events.
23 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/02/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/14/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/01/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/20/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/20/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/05/2022
PUBO
PUBLISHED FOR OPPOSITION
07/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/15/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
06/02/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
05/27/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/17/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
05/17/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/17/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
05/17/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/17/2022
DOCK
ASSIGNED TO EXAMINER
05/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/28/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/28/2022
ALIE
ASSIGNED TO LIE
04/21/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
04/19/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/20/2022
NWAP
NEW APPLICATION ENTERED
01/18/2022
Continuous trademark protection
Get notified about every new filing that threatens ENDO INJECTABLE SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.